JPRN-UMIN000001665已完成未知
Effect of drug metabolizing enzyme gene polymorphism on selective estrogen receptor modulator pharmacokinetics in breast cancer (JBCRG-12) - JBCRG-12 (Pharmacokinetics-pharmacogenomics study in breast cancer endocrine treatment)
JBCRG(Japan Breast Cancer Research Group)0 个研究点目标入组 273 人开始时间: 2009年2月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 273
研究概览
简要总结
The CYP2D6 genotype was the major determinant for TAM activity (p < 0.01). Smoking status (p = 0.07) and the CYP2C19 phenotype (p = 0.07), but not the CYP2D6 genotype (p = 0.61), showed marginally significant effects on TOR activity.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
已完成
1 期
Genetic Determinants of the Metabolism of Non-nucleoside Reverse Transcriptase InhibitorsHIV InfectionsNCT00730223Vanderbilt University33
已完成
不适用
Study of Cytochrome P450 Polymorphisms (CYP2D6, CYP3A4/5 and CYP2C19) in Breast Cancer PatientsBreast NeoplasmsSurvival AnalysisAntineoplastic AgentsTherapeutic UsesNCT01169792Yonsei University
招募中
不适用
Pharmacogenetic Determinants Of Treatment Response In ChildrenAll MalignanciesChildren Being Treated for Catastrophic IllnessNCT00730678St. Jude Children's Research Hospital8,800
已完成
不适用
CYPTAM study.women with early stage breast cancerusing adjuvant tamoxifenDutch:patientes met vroeg-stadium mammacarcinoom behandeld met adjuvant tamoxifenNL-OMON23389eiden University Medical Center (LUMC)Leiden, the Netherlands650
已完成
不适用
Determine the Effects of Gene Differences and Voriconazole on Enzyme CYP2B6 Activity in the Liver in Healthy VolunteersEfavirenz, Metabolism and Pharmacokinetics ChangesNCT01104376Indiana University61